Multidisciplinary Approaches to Cancer Symposium


8: 55 – 9:00 AM  Welcome & Announcements

9:00 – 9:40 AM  Targeted Therapy in Triple Negative Breast Cancer Update
Yuan Yuan, MD, PhD

9:45 – 10:25 AM  Advancement of HER2 Positive Breast Cancer
Joanne Mortimer, MD, FACP, FASCO

Plenary Session

10:30 – 11:10 AM Advancing CAR T Cells for the Treatment of Solid Tumors
Saul Priceman, PhD

12:15 – 1:00 PM  Maintenance Therapy for Ovarian Cancer
Mihaela Cristea, MD

1:00 – 1:40 PM  Role of Cytoreductive Surgery and HIPEC in the Management of Peritoneal Carcinomatosis
Mustafa Raoof, MD, MS

2:00 – 2:40 PM  Management of Tumor Related Endocrinopathies
Behrouz Salehian, MD

2:45 – 3:20 PM Ideal Sequence for Advanced Kidney Cancer Treatment
Sumanta Kumar Pal, MD


8:55 – 9:00 AM  Welcome & Announcements

9:00 – 9:40 AM  Optimizing Adjuvant Therapy for Patients with Colon Cancer
Jun Gong, MD
Cedars-Sinai Medical Center

9:45 – 10:25 AM Optimal Treatment Strategies for Localized Rectal Cancer

Facilitator: Lily L. Lai, MD, FACS
Medical Oncologist: Jun Gong, MD
Radiation Oncologist: Yi-Jen Chen, MD, PhD

Plenary Session

10:30 – 11:10 AM Genomic Testing in Oncology: Insights from the Tumor to the Germline
Jeffrey N. Weitzel, MD

12:15 – 1:00 PM Management of Borderline/Resectable Pancreatic Cancer

Surgery First: Laleh Melstrom, MD, FACS
Chemotherapy First: Vincent Chung, MD, FACP

1:00 – 1:40 PM  Tumor Board: Role of Liver Directed Therapies for Various GI Malignancies

Facilitator: Jonathan Kessler, MD
Medical Oncologist: Vincent Chung, MD, FACP
Surgical Oncologist: Laleh Melstrom, MD, FACS

2:00 – 2:40 PM  Coagulation in Cancer
Daphne Stewart, MD

2:45 – 3:20 PM    Evaluation and Management of Thrombocytopenia in the Oncology Patient
Vinod Pullarkat, MD


8:55 – 9:00 AM  Welcome & Announcements

9:00 – 9:40 AM  Case Discussion of Radiation/Surgical Treatments for Asymptomatic Oligometastatic Tumors

Radiation Oncologist: Arya Amini, MD
Surgical Oncologist: Gagandeep Singh, MD, FACS

9:45 – 10:25 AM Therapeutic Considerations for Advanced Melanoma- Does Sequence Determine Outcome?
Kim Margolin, MD

Plenary Session

10:30 – 11:10 AM Future of Personalized Oncology Trials
Sunil Sharma, MD, MBA
Translational Genomics Research Institute

12:15 – 1:00 PM Tumor Board: Expert Insights in the Treatment of Early and Advanced Non-small Cell Lung Cancer

Facilitator: Arya Amini, MD
Medical Oncologist: Karen L. Reckamp, MD, MS
Radiation Oncologist: Sagus Sampath, MD
Surgical Oncologist: Loretta Erhunmwunsee, MD, FACS

1:00 – 1:40 PM  Advanced Non-Small Cell Lung Cancer (NSCLC): Current Therapy Updates
Karen L. Reckamp, MD, MS

2:00 – 2:40 PM Current Treatment Landscape for Hepatocellular Carcinoma: Challenges and Opportunities
Daneng Li, MD

2:45 – 3:20 PM Survivorship and Supportive Care: Living with Cancer
William Dale, MD, PhD


8:55 – 9:00 AM  Welcome & Announcements

9:00 – 9:40 AM  The Emerging Role of Medical Cannabis and the Oncology Patient
Allison Winacoo, MSN, RN, CPNP, CPHON, BMTCN
UCLA Mattel Children’s Hospital

9:45 – 10:25 AM  Acknowledging, Reducing and Managing Patient Pain and Suffering
Christopher Okamoto, BSN, RN
Jennifer Shamai, MS, RN, AOCNS, BMTCN

10:30 – 11:10 AM Common Dermatologic Complications to Modern Cancer Therapeutics
Farah R. Abdulla, MD

Download all AJCC Cancer Staging Forms by clicking on the link below:

City of Hope may find it necessary to substitute faculty with comparable expertise on those rare occasions necessitated by illness, unforeseen scheduling conflicts or extraordinary occurrences.